CTMX
CytomX Therapeutics Inc
Price:  
2.40 
USD
Volume:  
1,347,013.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CTMX Relative Valuation

60.0%
Upside

As of 2025-07-09, the Relative Valuation of CytomX Therapeutics Inc (CTMX) is 3.84 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.40 USD, the upside of CytomX Therapeutics Inc based on Relative Valuation is 60.0%.

The range of the Relative Valuation is 3.04 - 5.38 USD.

Range Selected
Trailing P/E multiples 11.5x - 18.6x 13.1x
Forward P/E multiples 17.1x - 24.6x 19.3x
Fair Price 3.04 - 5.38 3.84
Upside 26.5% - 124.3% 60.0%
2.40 USD
Stock Price
3.84 USD
Fair Price

CTMX Relative Valuation - Historical P/E Data

Date P/E
2025-07-03 9.47
2025-07-02 9.39
2025-07-01 8.94
2025-06-30 8.60
2025-06-27 8.52
2025-06-26 8.75
2025-06-25 8.37
2025-06-24 8.10
2025-06-23 8.18
2025-06-20 8.79
2025-06-18 7.99
2025-06-17 9.01
2025-06-16 9.32
2025-06-13 10.41
2025-06-12 11.32
2025-06-11 10.68
2025-06-10 10.22
2025-06-09 9.98
2025-06-06 10.00
2025-06-05 9.09
2025-06-04 9.50
2025-06-03 10.03
2025-06-02 9.50
2025-05-30 10.03
2025-05-29 9.54
2025-05-28 9.09
2025-05-27 8.05
2025-05-23 8.44
2025-05-22 8.07
2025-05-21 7.72
2025-05-20 7.80
2025-05-19 8.07
2025-05-16 7.69
2025-05-15 7.57
2025-05-14 9.01
2025-05-13 9.47
2025-05-12 8.07
2025-05-09 3.52
2025-05-08 4.13
2025-05-07 3.64
2025-05-06 3.66
2025-05-05 3.64
2025-05-02 3.04
2025-05-01 2.87
2025-04-30 2.82
2025-04-29 2.47
2025-04-28 2.68
2025-04-25 2.69
2025-04-24 2.90
2025-04-23 2.77